LMAT Financial Facts

Cost of sales: 6.2M
Research and development: 1.54M
See Full Income Statement

Acquisition-related obligations: 608K
Other long-term liabilities: 872K
See Full Balance Sheet

LeMaitre Vascular (LMAT) Earnings

  |   Expand Research on LMAT
Next EPS Date 8/5/26 *Est. EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +2.8% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/30/26 Q126 N/A$0.61 N/A N/A$65.85M = N/A N/A
2/25/26 Q425 $0.68$0.66 +$0.02$64.45M$62.98M = Details
11/6/25 Q325 $0.62$0.57 +$0.05$61M$62.23M = Details
8/5/25 Q225 $0.60$0.57 +$0.03$64.2M$62.48M = Details
5/1/25 Q125 $0.48$0.51 -$0.03$59.9M$58.13M = Details
2/27/25 Q424 $0.49$0.46 +$0.03$55.7M$55.49M = Details
2/24/25 Q424 N/A$0.46 N/A N/A$55.49M = N/A N/A
2/21/25 Q424 N/A$0.46 N/A N/A$55.49M = N/A N/A